MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on March 23, 2005; DOI: 10.1124/mol.104.007799


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.104.007799v1
67/6/2102    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Peavy, R. D.
Right arrow Articles by Hepler, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Peavy, R. D.
Right arrow Articles by Hepler, J. R.


Received for publication October 1, 2004.
Revised March 23, 2005.
Accepted for publication March 23, 2005.

Differential effects of Gq{alpha}, G14{alpha} and G15{alpha} on vascular smooth muscle cells survival and gene expression profiles

Richard D. Peavy 1, Katherine B. Hubbard 1, Anthony G. Lau 2, R. Brett Fields 1, Kaiming Xu 1, C. Justin Lee 1, Terri T. Lee 1, Kim M. Gernert 1, T. J. Murphy 1, John R. Hepler 1*

1 Emory University School of Medicine 2 Emory Univeristy School of Medicine

* Address correspondence to: E-mail: jhepler{at}emory.edu

Abstract

Gq{alpha} family members (Gq{alpha}, G11{alpha}, G14{alpha} and G15/16{alpha}) stimulate phospholipase C{beta} (PLC{beta}) and inositol lipid signaling, but differ markedly in amino acid sequence and tissue distribution predicting unappreciated functional diversity. To examine functional differences, we compared the signaling properties of Gq{alpha}, G14{alpha} and G15{alpha} and their cellular responses in vascular smooth muscle cells (VSMC). Constitutively active forms of Gq{alpha}, G14{alpha} or G15{alpha} elicit markedly different responses when introduced to VSMC. Whereas each G{alpha} stimulated PLC{beta} to similar extents when expressed at equal protein levels, Gq{alpha} and G14{alpha}, but not G15{alpha} initiated profound cell death within 48 hours. This response was due to activation of apoptotic pathways since Gq{alpha} and G14{alpha}, but not G15{alpha}, stimulated caspase-3 activation and did not alter phospho-Akt, a regulator of cell survival pathways. Gq{alpha} and G14{alpha} stimulate NFAT activation in VSMC, but G{alpha}-induced cell death appears independent of PKC, InsP3/Ca++, and NFAT because pharmacological inhibitors of these pathways did not block cell death. Gene expression analysis indicates that Gq{alpha}, G14{alpha} and G15{alpha} each elicit markedly different profiles of altered gene sets in VSMC after 24 hrs. Whereas all three G{alpha} stimulated changes (≥2-fold) in 50 shared mRNA, Gq{alpha} and G14{alpha} (but not G15{alpha}) stimulated changes in 221 shared mRNA of which many are reported to be pro-apoptotic and/or involved with TNF{alpha} signaling. Surprisingly, each G{alpha} also stimulated changes in non-overlapping G{alpha}-specific gene sets. These findings demonstrate that Gq{alpha} family members activate both overlapping and distinct signaling pathways, and are more functionally diverse than previously thought.


Key words: Gq/11 family, Phospholipase C's, IP3/DAG, Calcium (G Protein Coupled Signals), Protein Kinase C, G protein regulation, NFAT, Regulation of gene expression, Cyclooxygenases





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics